NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Tags: heart disease

8/28/2018

Contrary to claims, heart scans don’t save lives, but subsequent interventions might

5/24/2018

Percutaneous coronary intervention (PCI) declared ‘better’ than drug therapy; readers worse off

2/27/2018

Heavy reliance on surrogate markers doesn’t tell full story of diet advantages

8/16/2017

Findings from a rat heart study can’t be extrapolated to people

1/4/2017

Fenofibrate as add-on to statins for type 2 diabetes: NIH release promotes possible benefit found only in small subgroup of patients

2/18/2016

Vague PR release oversells study on avocado cholesterol benefits

1 1/29/2016

Recycled PR release doesn’t tell us anything new about garlic

10/1/2015

Release on “groundbreaking” pre-school heart health study underwhelms on outcomes